Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KamadaXTAE:KMDA 91 EV-to-FCF is 15.97 as of Sep. 20, 2026, which is 6% above its 10-year median of 15.03. GuruFocus rates XTAE:KMDA with a GF Score™ of 91/100 and a GF Value™ of ₪25.97 (Fairly Valued). The stock has 1 warning sign investors should review. Among 572 Drug Manufacturers companies, Kamada ranks better than 58.92% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Kamada's Enterprise Value is ₪1,342.9 Mil.
Kamada's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₪84.1 Mil. Therefore, Kamada's EV-to-FCF for today is 15.97.
The historical rank and industry rank for Kamada's EV-to-FCF or its related term are showing as below:
XTAE:KMDA'
s EV-to-FCF Range Over the Past 10 Years
Min: -557.72 Med: 15.03 Max: 498.69
Current: 15.53
During the past 13 years, the highest EV-to-FCF of Kamada was 498.69. The lowest was -557.72. And the median was 15.03.
XTAE:KMDA's EV-to-FCF is ranked better than 58.92% of 572
companies
in the Drug Manufacturers industry
Industry Median: 18.89
vs XTAE:KMDA: 15.53
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-09-20), Kamada's stock price is ₪26.33.
Kamada's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ₪1.195. Therefore, Kamada's PE Ratio (TTM) for today is 22.03.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Kamada's share price for today is ₪26.33.
Kamada's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪1.195.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Kamada EV-to-FCF Related Terms
Kamada EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Kamada's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:KMDA vs ZTS, UTHR, VTRS: EV-to-FCF Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kamada's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kamada EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kamada's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Kamada's EV-to-FCF falls into.
Kamada's current Enterprise Value is ₪1,342.9 Mil.
Kamada's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪84.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kamada (XTAE:KMDA) has a EV-to-FCF of 15.97 as of Sep. 20, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Kamada and its competitors. This is near median its historical median of 15.03. According to the industry distribution chart, Kamada ranks #235 out of 572 companies in the Drug Manufacturers industry, placing it in the top 41.1%.
Is Kamada's EV-to-FCF too high?
Kamada's current EV-to-FCF of 15.97 is near median its 10-year median of 15.03. The Drug Manufacturers industry median EV-to-FCF is 18.89. Kamada's value of 15.97 is 15.5% below this industry median. Based on the distribution chart, Kamada ranks #235 out of 572 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Kamada has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kamada's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kamada ranks #235 out of 572 companies for EV-to-FCF. This puts Kamada in the upper half of its industry. The industry median EV-to-FCF is 18.89. Kamada's value of 15.97 is 15.5% below this benchmark. While the company's 10-year median is 15.03 vs. the industry median of 18.89, Kamada has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 18.89, based on 572 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kamada's current EV-to-FCF of 15.97 is 15.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Kamada and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 18.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kamada's current EV-to-FCF is 15.97, which is near median its own 10-year median of 15.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kamada stock overvalued right now?
Based on GuruFocus' analysis, Kamada (XTAE:KMDA) is currently considered Fairly Valued. The stock's GF Value™ is ₪25.97, compared to a current price of ₪26.33 — trading 1.4% above its estimated fair value. The current EV-to-FCF is 15.97, which is near median its 10-year median of 15.03 and 15.5% below the Drug Manufacturers industry median of 18.89. Kamada's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Kamada (XTAE:KMDA), the current EV-to-FCF is 15.97 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kamada (XTAE:KMDA) Overvalued in 2026?
Based on GuruFocus' analysis, Kamada stock appears to be overvalued.
The current stock price of ₪26.33 is trading 1.4% above its estimated GF Value™ of ₪25.97.
GuruFocus considers Kamada to be Fairly Valued.
Key valuation signals for XTAE:KMDA:
EV-to-FCF: 15.97 (near median its 10-year median of 15.03)
GF Value™: ₪25.97 vs. price of ₪26.33 (1.4% above fair value)
Industry Position: 15.5% below the Drug Manufacturers median (#235 of 572)
No single metric tells the full story. See the XTAE:KMDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
91GF Score
Get the complete analysis for XTAE:KMDA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:KMDA has been successfully added to your 
